Progentec is engaged in state of the art diagnostic interventions in therapeutic areas with a high level of unmet need. Founded by Mohan Purushothaman in 2015, Progentec Diagnostics is backed by investors that include Stanford University, NMC Health, Mayo Clinic Ventures, OCA Ventures, and Oklahoma Seed Capital Fund and is headquartered in Oklahoma City, Oklahoma.